title: Invasion of human aortic endothelial cells by oral viridans group streptococci and induction of inflammatory cytokine production.
abstract: Oral viridans group streptococci are the major commensal bacteria of the supragingival oral biofilm and have been detected in human atheromatous plaque. Atherosclerosis involves an ongoing inflammatory response, reportedly involving chronic infection caused by multiple pathogens. The aim of this study was to examine the invasion of human aortic endothelial cells (HAECs) by oral viridans group streptococci and the subsequent cytokine production by viable invaded HAECs. The invasion of HAECs by bacteria was examined using antibiotic protection assays and was visualized by confocal scanning laser microscopy. The inhibitory effects of catalase and cytochalasin D on the invasion of HAECs were also examined. The production of cytokines by invaded or infected HAECs was determined using enzyme-linked immunosorbent assays, and a real-time polymerase chain reaction method was used to evaluate the expression of cytokine messenger RNA. The oral streptococci tested were capable of invading HAECs. The number of invasive bacteria increased with the length of the co-culture period. After a certain co-culture period, some organisms were cytotoxic to the HAECs. Catalase and cytochalasin D inhibited the invasion of HAECs by the organism. HAECs invaded by Streptococcus mutans Xc, Streptococcus gordonii DL1 (Challis), Streptococcus gordonii ATCC 10558 and Streptococcus salivarius ATCC 13419 produced more cytokine(s) (interleukin-6, interleukin-8, monocyte chemoattractant protein-1) than non-invaded HAECs. The HAECs invaded by S. mutans Xc produced the largest amounts of cytokines, and the messenger RNA expression of cytokines by invaded HAECs increased markedly compared with that by non-invaded HAECs. These results suggest that oral streptococci may participate in the pathogenesis of atherosclerosis.
authors.affiliation: Department of Preventive Dentistry, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
authors.forename: E
authors.initials: E
authors.lastname: Nagata
authors.forename: A
authors.initials: A
authors.lastname: de Toledo
authors.forename: T
authors.initials: T
authors.lastname: Oho
mesh_terms: D001011:Aorta / Q000166:cytology / Q000382:microbiology*; D050197:Atherosclerosis / Q000382:microbiology; D002374:Catalase / Q000494:pharmacology; D002478:Cells, Cultured; D018932:Chemokine CCL2 / Q000096:biosynthesis; D018920:Coculture Techniques; D015638:Cytochalasin D / Q000494:pharmacology; D016207:Cytokines / Q000096:biosynthesis*; D042783:Endothelial Cells / Q000276:immunology / Q000382:microbiology*; D004730:Endothelium, Vascular / Q000166:cytology / Q000382:microbiology*; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism*; D015850:Interleukin-6 / Q000096:biosynthesis; D016209:Interleukin-8 / Q000096:biosynthesis; D018613:Microscopy, Confocal; D009055:Mouth / Q000382:microbiology*; D013291:Streptococcus / Q000502:physiology; D034366:Streptococcus anginosus / Q000502:physiology; D054773:Streptococcus gordonii / Q000502:physiology; D034367:Streptococcus intermedius / Q000502:physiology; D034361:Streptococcus mitis / Q000502:physiology; D013295:Streptococcus mutans / Q000502:physiology; D019533:Streptococcus oralis / Q000502:physiology; D034363:Viridans Streptococci / Q000187:drug effects / Q000276:immunology / Q000502:physiology*; D014774:Virulence
chemical_list: D018932:Chemokine CCL2; D016207:Cytokines; D018836:Inflammation Mediators; D015850:Interleukin-6; D016209:Interleukin-8; D015638:Cytochalasin D; D002374:Catalase